Axogen, Inc. reported financial results and business highlights for the fourth quarter and full-year ended December 31, 2023. Fourth quarter 2023 financial results and business highlights...
Nyxoah SA reported financial and operating results for the fourth quarter and financial year 2023. 2024 strategic priorities Complete patient follow up in the DREAM U.S....
NeuroPace, Inc. reported financial results for the fourth quarter and full year ended December 31, 2023. “This is an exciting period in our Company’s history as...
Orthofix Medical Inc. reported its financial results for the fourth quarter and year ended December 31, 2023, and issued guidance for the full year 2024. Fourth...
Stereotaxis reported financial results for the fourth quarter and full year ended December 31, 2023. “We enter 2024 having made significant progress in realizing our strategic...
The U.S. Food and Drug Administration cleared for marketing the first over-the-counter (OTC) continuous glucose monitor (CGM). The Dexcom Stelo Glucose Biosensor System is an integrated...
Agiliti Inc. announced its financial results for the fourth quarter and year ended December 31, 2023. Fourth quarter and year-to-date 2023 financial results Total revenue for...
Autonomous Medical Devices Incorporated (AMDI) has received a National Institutes of Health (NIH) RADx Tech award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB),...
Haemonetics Corporation announced that it has entered into a definitive agreement to acquire privately-held Chicago-based Attune Medical, the manufacturer of the ensoETM® proactive esophageal cooling device,...
Boston Scientific Corporation announced it has received U.S. Food and Drug Administration (FDA) approval for the AGENT™ Drug-Coated Balloon (DCB), which is indicated to treat coronary...
Innsena announced the appointment of Britteny Matero to partner and senior vice president. As partner and senior vice president, Matero assumes leadership of the Innsena market...
Phagenesis has closed a $42M Series D financing all equity investment round. The combined European and United States investment syndicate was led by EQT Life Sciences,...
iRhythm Technologies, Inc. announced the pricing of its offering of $575.0 million aggregate principal amount of 1.50% Convertible Senior Notes due 2029 (the “notes”) in a...
Bone Biologics Corporation announced the pricing of its public offering of an aggregate of 781,251 shares of its common stock (or common stock equivalents in lieu...
Halma announced that it has acquired Rovers Medical Devices (Rovers). Cervical cancer claims a woman’s life every two minutes. It is the fourth most common cancer...
Copyright © 2024 Medical Buyer